# OnCo record voronoi (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/voronoi/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "voronoi" ;
  schema:name "Voronoi"@en ;
  schema:alternateName "Voronoi, Inc"@en, "Voronoi Inc."@en ;
  schema:description "Voronoi is a Korean company making tablets that block specific cancer-driving enzymes, designed to reach the brain, where lung and breast cancers often spread. It has drugs in early trials for EGFR-mutant lung cancer and HER2-positive tumours."@en ;
  schema:url <https://onco.cc/companies/voronoi/>, <https://voronoi.io/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://voronoi.io/>, <https://voronoi.io/pipeline.html>, <https://clinicaltrials.gov/study/NCT06806982>, <https://clinicaltrials.gov/study/NCT07699328> ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/her2-tyrosine-kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/her2/> .